论文部分内容阅读
目的:观察并总结肺栓塞、溶栓及抗凝疗法的治疗效果.方法:31例肺栓塞分别采用尿激酶溶栓、肝素抗凝治疗及对症治疗,并在治疗前后根据临床表现及核素肺灌注显像进行分析.结果:9例用尿激酶溶栓治疗组治愈2例,显效2例,好转3例,有效1例,无效1例,总有效率88.9%;8例抗凝治疗者治愈1例,显效1例,好转3例,有效1例,无效2例,总有效率75%;未用溶栓和抗凝方法治疗14例,好转2例,有效1例,无效11例,总有效率仅为21.4%.溶栓及抗凝治疗中未见严重出血及其他副作用.结论:急性肺栓塞患者早期使用尿激酶进行溶栓治疗可取得较好的临床疗效.
Objective: To observe and summarize the therapeutic effect of pulmonary embolism, thrombolytic therapy and anticoagulation therapy.Methods: 31 cases of pulmonary embolism were treated with urokinase thrombolysis, heparin anticoagulation therapy and symptomatic treatment, and according to the clinical manifestations and radionuclide lung Perfusion imaging analysis.Results: 9 cases of urokinase thrombolytic therapy group cured 2 cases, 2 cases markedly improved, 3 cases improved, 1 case effective, 1 case ineffective, the total effective rate was 88.9%; 8 cases of anticoagulant treatment were cured 1, markedly effective in 1, improved in 3, effective in 1, ineffective in 2, with a total effective rate of 75%; without thrombolysis and anticoagulation treatment in 14 cases, improved in 2 cases, effective in 1 case, ineffective in 11 cases, total The effective rate was only 21.4% .There was no serious bleeding and other side effects in the thrombolytic and anticoagulant therapy.Conclusion: Early use of urokinase for thrombolytic therapy in patients with acute pulmonary embolism can achieve better clinical efficacy.